Tenofovir versus entecavir in treatment of chronic hepatitis B virus with severe acute exacerbation

Antimicrobial Agents and Chemotherapy
Chao-Hung HungChien-Hung Chen

Abstract

Tenofovir disoproxil fumarate (TDF) and entecavir (ETV) are effective antivirals recommended as first-line monotherapies for treatment of chronic hepatitis B (CHB) infection. This study aimed to compare the short-term efficacies of TDF and ETV in the treatment of CHB with severe acute exacerbation. From 2008 to 2013, 189 consecutive treatment-naive CHB patients receiving TDF (n = 41) or ETV (n = 148) for severe acute exacerbation were enrolled. The primary endpoint was overall mortality or receipt of liver transplantation by week 24. The baseline characteristics were comparable between these two groups. By week 24, 8 (19% [95% confidence interval {CI}, 7% to 32%]) patients in the TDF group and 26 (18% [95% CI, 11 to 24%]) patients in the ETV group died (n = 30) or received liver transplantation (n = 4) (P = 0.749). The two groups of patients developed similar rates of liver-related complications and achieved comparable biochemical and virological responses at week 24. Cox regression analysis showed that baseline viral DNA level (P = 0.002), hypertension (P = 0.002), model for end-stage liver disease (MELD) score (P = 0.01), platelet count (P = 0.005), early presence (within 4 weeks) of ascites (P = 0.005), hepatic encephalopath...Continue Reading

References

Dec 11, 1997·The New England Journal of Medicine·W M Lee
Mar 18, 2003·Journal of Gastroenterology·Chao-Hung HungChi-Sin Changchien
Jan 16, 2004·Gastroenterology·Anna S F LokMary Castiglia
Jul 28, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Stephen N Wong, Anna S F Lok
Dec 5, 2008·The New England Journal of Medicine·Patrick MarcellinFranck Rousseau
Mar 13, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Daniel J TenneyRichard J Colonno
Aug 12, 2009·Hepatology International·Yun-Fan LiawUNKNOWN Chronic Hepatitis B Guideline Working Party of the Asian-Pacific Association for the Study of the Liver
Aug 18, 2009·Journal of Gastroenterology and Hepatology·Vincent Wai-Sun Wong, Henry Lik-Yuen Chan
Aug 29, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Anna S F Lok, Brian J McMahon
Nov 26, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Christian M LangeChristoph Sarrazin
Dec 9, 2009·Journal of Gastroenterology and Hepatology·Li-Jie SunShu-Chen Li
Jun 26, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jessica A DavilaHashem B El-Serag
Oct 30, 2010·Journal of Hepatology·Vincent Wai-Sun WongHenry Lik-Yuen Chan
Dec 25, 2010·Therapeutic Advances in Gastroenterology·Andrés Duarte-Rojo, E Jenny Heathcote
Feb 5, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hitendra GargAshish Kumar
Nov 22, 2011·Liver International : Official Journal of the International Association for the Study of the Liver·Hans L TillmannGeorge N Dalekos
Mar 23, 2012·Journal of Hepatology·UNKNOWN European Association For The Study Of The Liver
Jul 17, 2012·The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology·Ümit Bilge DoğanMustafa Salih Akin
Jan 11, 2013·Liver International : Official Journal of the International Association for the Study of the Liver·Ankur JindalShiv K Sarin
Oct 19, 2013·Expert Review of Gastroenterology & Hepatology·Joanna K MooreKenneth J Simpson
Jun 1, 2012·Hepatology International·Yun-Fan LiawMasao Omata

❮ Previous
Next ❯

Citations

Nov 6, 2015·International Journal of Molecular Sciences·Sha LiYibin Feng
Dec 26, 2015·International Journal of Molecular Sciences·Wei-Lun TsaiJin-Shiung Cheng
Nov 14, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Anna S F LokKhaled Mohammed
Nov 14, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Norah A TerraultUNKNOWN American Association for the Study of Liver Diseases
Jul 10, 2016·Asian Pacific Journal of Tropical Medicine·David Olusoga OgboluAdeolu S Oluremi
Jul 1, 2017·Expert Review of Gastroenterology & Hepatology·Yiqi YuWenhong Zhang
Jan 7, 2017·World Journal of Gastroenterology : WJG·Chong ChenLiang Chen
Nov 30, 2018·Alimentary Pharmacology & Therapeutics·Ming-Te KuoChien-Hung Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.